February 3, 2025 - 14:47

Evolv Technology has been granted a crucial extension by Nasdaq, allowing the company until May 19, 2025, to file its Q3 2024 financial report. This extension is significant for Evolv as it navigates the complexities of compliance with exchange regulations. The additional time will enable the company to ensure that its financial reporting meets the necessary standards and requirements.
To further enhance its financial reporting capabilities, Evolv has partnered with AlixPartners, a global consulting firm known for its expertise in improving operational efficiency. This collaboration aims to streamline the financial reporting process, ensuring timely and accurate submissions moving forward.
The extension and partnership come at a pivotal time for Evolv Technology, as it seeks to bolster investor confidence and maintain its standing in the competitive tech landscape. With these strategic moves, the company is positioning itself for future growth and stability in the marketplace.
February 24, 2026 - 22:10
Solvent‑free perovskite solar cell technology could pave way for scalable productionA significant advancement in solar technology has been achieved with the development of a new, solvent-free manufacturing process for perovskite solar cells. This innovation promises to overcome...
February 24, 2026 - 01:59
Peptides are everywhere. Here’s what you need to know.Peptides, the short chains of amino acids that serve as building blocks for proteins, have surged from scientific journals into mainstream wellness and skincare conversations. These compounds are...
February 23, 2026 - 05:11
A New Strategy Needed in the Fight Against Digital FraudThe current crackdown on online financial scams may be focusing on the wrong targets. While major tech platforms face increasing pressure to police their ecosystems, experts are questioning if this...
February 22, 2026 - 04:45
Emerging embryo-selection technologies are currently 'little more than snake oil.' But someday, they could widen social inequities.The burgeoning field of embryo-selection technology, often marketed with grand promises, is currently under intense scrutiny. Experts analyzing the landscape describe many present offerings as...